These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 22842982)
1. Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients. Liu F; Li Y; Ren M; Zhang X; Guo X; Lang R; Gu F; Fu L Breast Cancer Res Treat; 2012 Sep; 135(2):459-67. PubMed ID: 22842982 [TBL] [Abstract][Full Text] [Related]
2. CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Liu F; Lang R; Zhao J; Zhang X; Pringle GA; Fan Y; Yin D; Gu F; Yao Z; Fu L Breast Cancer Res Treat; 2011 Nov; 130(2):645-55. PubMed ID: 21717105 [TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients. Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z Digestion; 2012; 86(4):329-37. PubMed ID: 23207161 [TBL] [Abstract][Full Text] [Related]
4. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection. Wang B; Xu D; Yu X; Ding T; Rao H; Zhan Y; Zheng L; Li L Ann Surg Oncol; 2011 Sep; 18(9):2585-93. PubMed ID: 21347781 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma. Li JF; Chu YW; Wang GM; Zhu TY; Rong RM; Hou J; Xu M BJU Int; 2009 Feb; 103(3):399-405. PubMed ID: 19021626 [TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer. Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453 [TBL] [Abstract][Full Text] [Related]
7. Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy. Ladoire S; Arnould L; Mignot G; Coudert B; Rébé C; Chalmin F; Vincent J; Bruchard M; Chauffert B; Martin F; Fumoleau P; Ghiringhelli F Breast Cancer Res Treat; 2011 Jan; 125(1):65-72. PubMed ID: 20229175 [TBL] [Abstract][Full Text] [Related]
8. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. von Minckwitz G; Untch M; Blohmer JU; Costa SD; Eidtmann H; Fasching PA; Gerber B; Eiermann W; Hilfrich J; Huober J; Jackisch C; Kaufmann M; Konecny GE; Denkert C; Nekljudova V; Mehta K; Loibl S J Clin Oncol; 2012 May; 30(15):1796-804. PubMed ID: 22508812 [TBL] [Abstract][Full Text] [Related]
9. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Demir L; Yigit S; Ellidokuz H; Erten C; Somali I; Kucukzeybek Y; Alacacioglu A; Cokmert S; Can A; Akyol M; Dirican A; Bayoglu V; Sari AA; Tarhan MO Clin Exp Metastasis; 2013 Dec; 30(8):1047-62. PubMed ID: 23836289 [TBL] [Abstract][Full Text] [Related]
10. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832 [TBL] [Abstract][Full Text] [Related]
11. An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer. Mahmoud SM; Paish EC; Powe DG; Macmillan RD; Lee AH; Ellis IO; Green AR Breast Cancer Res Treat; 2011 May; 127(1):99-108. PubMed ID: 20556505 [TBL] [Abstract][Full Text] [Related]
12. FOXP3 expression is related to high Ki-67 index and poor prognosis in lymph node-positive breast cancer patients. Kim MH; Koo JS; Lee S Oncology; 2013; 85(2):128-36. PubMed ID: 23948758 [TBL] [Abstract][Full Text] [Related]
13. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells. Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540 [TBL] [Abstract][Full Text] [Related]
14. [Tumor-infiltrating FoxP3+ Tregs are associated with CD34 expression and prognosis of hepatocellular carcinoma]. Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; DU Z Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):25-9. PubMed ID: 22464702 [TBL] [Abstract][Full Text] [Related]
15. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival. Ladoire S; Mignot G; Dabakuyo S; Arnould L; Apetoh L; Rébé C; Coudert B; Martin F; Bizollon MH; Vanoli A; Coutant C; Fumoleau P; Bonnetain F; Ghiringhelli F J Pathol; 2011 Jul; 224(3):389-400. PubMed ID: 21437909 [TBL] [Abstract][Full Text] [Related]
16. Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis. Gupta S; Joshi K; Wig JD; Arora SK Acta Oncol; 2007; 46(6):792-7. PubMed ID: 17653902 [TBL] [Abstract][Full Text] [Related]
17. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038 [TBL] [Abstract][Full Text] [Related]
18. Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus. Zingg U; Montani M; Frey DM; Dirnhofer S; Esterman AJ; Went P; Oertli D Eur J Surg Oncol; 2010 Jul; 36(7):670-7. PubMed ID: 20510571 [TBL] [Abstract][Full Text] [Related]
19. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma. Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942 [TBL] [Abstract][Full Text] [Related]
20. Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients. Oda N; Shimazu K; Naoi Y; Morimoto K; Shimomura A; Shimoda M; Kagara N; Maruyama N; Kim SJ; Noguchi S Breast Cancer Res Treat; 2012 Nov; 136(1):107-16. PubMed ID: 22986814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]